TP53 and cancer: Tumors from p53+/C;Erbb2 mice expressed higher levels of E-cadherin and pan cytokeratin (PCK) than the p53+/+;Erbb2 control, indicating their epithelial origin and slower cancer progression in p53 polymorphic mice (Supplementary Fig. 2b, c).